Market Capitalization (Millions $) |
343 |
Shares
Outstanding (Millions) |
26 |
Employees |
- |
Revenues (TTM) (Millions $) |
59 |
Net Income (TTM) (Millions $) |
-38 |
Cash Flow (TTM) (Millions $) |
4 |
Capital Exp. (TTM) (Millions $) |
0 |
Neuropace Inc
Neuropace Inc is a medical device company that specializes in developing and manufacturing neurostimulation systems for the treatment of neurological disorders. The company is known for its innovative RNS System, which stands for Responsive Neurostimulation System. This system is designed to detect and respond to abnormal electrical activity in the brain, providing therapy to patients suffering from epilepsy.
The RNS System consists of a small implantable device that is placed in the skull and connected to electrodes placed on or in the brain. It continuously monitors brain activity and delivers electrical pulses in response to abnormal patterns, helping to prevent seizures.
Neuropace Inc's RNS System is the first and only FDA-approved brain-responsive neurostimulation system for the treatment of refractory epilepsy. It offers a personalized and adaptive approach to managing seizures, with the potential to improve the quality of life for patients who are not adequately controlled by medication alone.
The company is headquartered in Mountain View, California, and operates globally, offering its neurostimulation technology to patients and healthcare professionals worldwide. Neuropace Inc is committed to further advancing the field of neuromodulation and exploring the potential of neurostimulation for the treatment of various neurological disorders.
Company Address: 455 N. Bernardo Avenue Mountain View 94043 CA
Company Phone Number: 237-2700 Stock Exchange / Ticker: NASDAQ NPCE
|